Patents Issued in March 27, 2007
-
Patent number: 7196199Abstract: The present invention relates to a phenoxypropylamine compound of the formula (I) wherein each symbol is as defined in the specification, an optically active compound thereof or a pharmaceutically acceptable salt thereof and hydrates thereof, which simultaneously show selective affinity for and antagonistic activity against 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity, and can be used as antidepressants quick in expressing an anti-depressive effect.Type: GrantFiled: December 22, 2003Date of Patent: March 27, 2007Assignee: Mitsubishi Pharma CorporationInventors: Akira Nishiyama, Masahiro Bougauchi, Takanobu Kuroita, Masanori Minoguchi
-
Patent number: 7196200Abstract: Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.Type: GrantFiled: January 21, 2004Date of Patent: March 27, 2007Assignee: Abbott LaboratoriesInventors: David D. Anderson, Bruce A. Beutel, Curt S. Cooper, Yu-Gui Gu, Mira M. Hinman, Douglas M. Kalvin, Robert F. Keyes, Xenia B. Searle, Rolf Wagner
-
Patent number: 7196201Abstract: The present invention relates to novel compounds, their use for inhibiting serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV) and to methods for their production and their therapeutic utilityType: GrantFiled: June 26, 2002Date of Patent: March 27, 2007Assignee: SmithKline Beecham CorporationInventors: Curt Dale Haffner, Darryl Lynn McDougald, Amarjit Sab Randhawa, Steven Michael Reister, David N Deaton
-
Patent number: 7196202Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compoundsType: GrantFiled: February 24, 2005Date of Patent: March 27, 2007Assignee: Schering AGInventors: Thorsten Blume, Wolfgang Halfbrodt, Joachim Kuhnke, Ursula Monning, Herbert Schneider
-
Patent number: 7196203Abstract: The present invention provides novel phenol derivatives represented by the formula: wherein the carbon atom marked with (S) represents a carbon atom in S configuration; Z represents the group represented by the formula: or the formula: wherein the carbon atoms marked with (R) represents a carbon atom in R configuration, and a method to produce a phenol derivative represented by the formula (A): (wherein the carbon atom marked with (R) and (S) have the same meanings as defined above) which comprises using any of those derivatives as an intermediate therefore.Type: GrantFiled: June 26, 2003Date of Patent: March 27, 2007Assignee: Kissei Pharmaceutical Co., Ltd.Inventors: Toshiaki Yamaguchi, Masaaki Ban, Takashi Yanagi, Ken Kikuchi, Minoru Kubota, Tetsuji Ozawa
-
Patent number: 7196204Abstract: Process for the synthesis of (2S)-indoline-2-carboxylic acid of formula (I): Application in the synthesis of perindopril and its pharmaceutically acceptable salts.Type: GrantFiled: April 7, 2004Date of Patent: March 27, 2007Assignee: Les Laboratoires ServierInventors: Jean-Claude Souvie, Jean-Pierre Lecouve
-
Patent number: 7196205Abstract: Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose: N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.Type: GrantFiled: March 28, 2005Date of Patent: March 27, 2007Assignees: The Regents of the University of Michigan, Genzyme CorporationInventors: Craig Siegel, James A. Shayman, Carol A. Nelson, David J. Harris, Diane P. Copeland
-
Patent number: 7196206Abstract: The invention relates to asymmetrical linear organic oligomers represented by the following formula (I), X—R1ArnR2 ??(I) in which n is from 4 to 10, Ar is for example an optionally substituted 2,5-thienylene group, R1 is for example a C10–C20 alkylene group, R2 is for example a C1–C12 alkyl group, and X is for example a vinyl group or an alkoxysilyl group. Also described is a process for the production of such organic oligomers, and semiconductors in electronic modules that include such organic oligomers.Type: GrantFiled: November 9, 2004Date of Patent: March 27, 2007Assignee: H.C. Starck GmbH & Co. KGInventors: Stephan Kirchmeyer, Sergei Ponomarenko, Marcus Halik
-
Patent number: 7196207Abstract: A method for reducing a sulfur-containing compound by hydrogenation using a noble metal catalyst which method is exemplified by an industrial method for producing a 2-alkyl-3-aminothiophene derivative with high economical efficiency by hydrogenating a 2-alkenyl-3-aminothiophene derivative using the noble metal catalyst. 2-Alkyl-3-aminothiophene derivatives are useful compounds in the fields of medicine and agriculture, and in particular, useful in bactericides for agriculture or gardening, or intermediates of the bactericides. The hydrogenation reaction temperature is controlled at 150° C. to 300° C. and the method allows the used noble metal catalyst to be recovered and reused.Type: GrantFiled: July 22, 2003Date of Patent: March 27, 2007Assignee: Mitsui Chemicals, Inc.Inventors: Daisuke Ura, Hiroyuki Katsuta, Toshio Kitashima, Kenichi Sato
-
Patent number: 7196208Abstract: This invention relates to processes for the preparation of 7-carboxy substituted steroid compounds of Formula I, wherein R1 is selected from H or COR4; R4 is C1–C6 alkyl or C1–C6 alkoxy; R3 is C1–C6 alkyl; Z1 is —CH2— or ?wherein O—COR4 is in the ? configuration; Z2 is —CH—; or Z1 and Z2 may be taken together to form a carbon-carbon double bond; Q is These intermediates are useful in the preparation of 7-carboxy substituted steroid compounds, and particularly, the invention is directed to novel and advantageous methods for the preparation of 9,11-?-epoxy-17-?-hydroxy-3-oxopregn-4-ene-?-7-21-dicarboxylic acid, ?-lactone, methyl ester (eplerenone; epoxymexrenone).Type: GrantFiled: March 21, 2003Date of Patent: March 27, 2007Inventor: Peter Guillaume Marie Wuts
-
Patent number: 7196209Abstract: The present invention is directed to a continuous process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein R1, R3, R4, R5, R6 and X are as herein defined. The present invention is further directed to a continuous process for the preparation of Topiramate.Type: GrantFiled: October 23, 2003Date of Patent: March 27, 2007Assignee: Ortho-McNeil Pharmaceutical, Inc.Inventors: Thomas W. Adkins, Charles F. Cicco, Penina Feibush, Donald A. Koch, Cynthia Maryanoff, Walter E. Stalzer
-
Patent number: 7196210Abstract: The ability to design and construct solid-state materials with pre-determined structures is a grand challenge in chemistry. An inventive strategy based on reticulating metal ions and organic carboxylate links into extended networks has been advanced to a point that has allowed the design of porous structures in which pore size and functionality can be varied systematically. MOF-5, a prototype of a new class of porous materials and one that is constructed from octahedral Zn—O—C clusters and benzene links, was used to demonstrate that its 3-D porous system can be functionalized with the organic groups, —Br, —NH2, —OC3H7, —OC5H11, —H4C2, and —H4C4, and its pore size expanded with the long molecular struts biphenyl, tetrahydropyrene, pyrene, and terphenyl.Type: GrantFiled: May 2, 2005Date of Patent: March 27, 2007Assignee: The Regents of the University of MichiganInventors: Omar M. Yaghi, Mohamed Eddaoudi, Hailian Li, Jaheon Kim, Nathaniel Rosi
-
Patent number: 7196211Abstract: A hafnium-containing material is presented for forming a film having excellent vaporization stability and higher film formation rate. Also a method for producing the film is presented. The hafnium-containing material for film formation has a bond of a hafnium atom with a nitrogen atom, or a bond of a hafnium atom and an oxygen atoms. Zr content contained in the material is equal to or less than 650 ppm.Type: GrantFiled: September 9, 2004Date of Patent: March 27, 2007Assignee: Mitsubishi Materials CorporationInventors: Atsushi Itsuki, Nobuyuki Soyama, Akio Yanagisawa
-
Patent number: 7196212Abstract: Novel perfluoropolyether-modified silanes are improved in water/oil repellency, parting properties, chemical resistance, lubricity, durability, antifouling properties and fingerprint wipe-off. An antireflection filter is also provided comprising an inorganic antireflection layer including a surface layer in the form of a silicon dioxide-base inorganic layer, and an antifouling layer, preferably of the perfluoropolyether-modified silane, on the surface layer. The antifouling layer has a sliding angle of oleic acid of up to 5°, a change of the sliding angle after solvent washing relative to the sliding angle before solvent washing being up to 10%.Type: GrantFiled: October 4, 2002Date of Patent: March 27, 2007Assignee: Shin-Etsu Chemical Co., Ltd.Inventors: Koichi Yamaguchi, Hirofumi Kishita
-
Patent number: 7196213Abstract: Provided are a process for producing a phosphate and a process for stabilizing a phosphate, the phosphate being an acid-form phosphate wherein an organic hydroxy compound is an alkylene oxide adduct. A production process of a phosphate and a stabilization process of a phosphate, including the step 1 of reacting an organic hydroxy compound represented by the following general formula (I) with a phosphorylating agent: R1—O—(AO)n—H??(I) wherein R1 represents a straight or branched alkyl group or alkenyl group having 6 to 36 carbon atoms, AO represents an oxyalkylene group having 2 to 4 carbon atoms, and n is a number of 0.1 to 100 on the average; the step 2 of purifying the reaction product obtained in the step 1 until the content of the organic hydroxy compound that has not yet reacted becomes 2% or less by weight; and the step 3 of adding water to the purified product obtained in the step 2 at such a ratio that the content of water in the final product is from 0.5 to 10% by weight.Type: GrantFiled: December 23, 2003Date of Patent: March 27, 2007Assignee: Kao CorporationInventors: Akira Matsunaga, Satoru Kijima
-
Patent number: 7196214Abstract: 4-aminobiphenyl derivative arylamine compounds are formed by providing an iodinated organic compound; substituting the iodinated organic compound at carboxylic acid groups thereof to provide ester protecting groups; conducting an Ullman condensation reaction to convert the product of step (ii) into an arylamine compound; and conducting a Suzuki coupling reaction to add an additional phenyl group to the arylamine compound in the 4-position relative to the nitrogen.Type: GrantFiled: November 22, 2004Date of Patent: March 27, 2007Assignee: Xerox CorporationInventors: H. Bruce Goodbrand, Timothy P. Bender, Jennifer A. Coggan, Nan-Xing Hu
-
Patent number: 7196215Abstract: Disclosed is a process for the production of terephthalic acid by a plurality of process steps including the catalyst oxidation of a dialkylbenzene compound, a second oxidation, a hydrogenation of the product of the second oxidation, and crystallization of the hydrogenation terephthalic acid using a plurality of series-connected crystallizers.Type: GrantFiled: May 31, 2002Date of Patent: March 27, 2007Assignee: Eastman Chemical CompanyInventors: Robert Lin, Ruairi Seosamh O'Meadhra, Ronald Buford Sheppard
-
Patent number: 7196216Abstract: A process for producing gabapentin, (1-(aminomethyl)-1-cyclohexaneacetic acid) from gabapentin hydrochloride salt. In the disclosed process, the gabapentin hydrochloride is converted to gabapentin using an inorganic base, such as barium hydroxide. Gabapentin hydrochloride is converted to gabapentin sulfate which in turn is converted to free base using barium hydroxide. The process is directed to improvement in the manufacture of gabapentin which would be industrially feasible and effective. Gabapentin obtained following the process of the invention is suitable as a drug especially in the treatment of cerebral diseases such as epilepsy.Type: GrantFiled: November 18, 2002Date of Patent: March 27, 2007Assignee: Nicholas Piramal India LimitedInventors: Jagdish Chand Saigal, Rajender Pershad Gupta, Rajesh Vinodrai Naik, Araddy Rajshekhar, Rajesh Dilip Joshi
-
Patent number: 7196217Abstract: Process for operating a continuous heterogeneously catalyzed gas phase partial oxidation of at least one organic compound using compressed air as the oxygen source which is filtered before its compression.Type: GrantFiled: August 6, 2004Date of Patent: March 27, 2007Assignee: BASF AktiengesellschaftInventors: Volker Schliephake, Ulrich Hammon, Rolf-Dieter Becher, Klaus Joachim Muller-Engel
-
Patent number: 7196218Abstract: A modified water-immiscible solvent useful in the extraction of acetic acid from aqueous streams is a substantially pure mixture of isomers of highly branched di-alkyl amines. Solvent mixtures formed of such a modified solvent with a desired co-solvent, preferably a low boiling hydrocarbon, are useful in the extraction of acetic acid from aqueous gaseous streams. An anaerobic microbial fermentation process for the production of acetic acid employs such solvents, under conditions which limit amide formation by the solvent and thus increase the efficiency of acetic acid recovery. Methods for the direct extraction of acetic acid and the extractive fermentation of acetic acid also employ the modified solvents and increase efficiency of acetic acid production. Such increases in efficiency are also obtained where the energy source for the microbial fermentation contains carbon dioxide and the method includes a carbon dioxide stripping step prior to extraction of acetic acid in solvent.Type: GrantFiled: May 5, 2004Date of Patent: March 27, 2007Assignees: Celanese International Corporation, Bioengineering Resources, Inc.Inventors: James L. Gaddy, Edgar C. Clausen, Ching-Whan Ko, Leslie E. Wade, Carl V. Wikstrom
-
Patent number: 7196219Abstract: A process for preparing anilineboronic acid derivative of the formula I, by converting an aniline to a diprotected aniline by introducing two protecting groups, metalating the diprotected aniline with a metalating agent and simultaneously or subsequently reacting with a boronic ester B(OR1,2,3)3 to form a protected anilineboronic ester, which is converted, by detaching the protecting groups, to the anilineboronic esters of the formula (I).Type: GrantFiled: May 14, 2004Date of Patent: March 27, 2007Assignee: Archimica GmbHInventors: Stefan Scherer, Andreas Meudt, Bernd Lehnemann, Alexei Kalinin, Victor Snieckus
-
Patent number: 7196220Abstract: The present invention relates to compounds of the formula or pharmaceutically acceptable salts thereof, useful for delivering agents having the capacity to diagnose, treat or prevent bone injury or disease to the bone for interaction therewith.Type: GrantFiled: December 22, 2004Date of Patent: March 27, 2007Assignee: University of Louisville Research Foundation, Inc.Inventors: William M. Pierce, Jr., Leonard C. Waite, K. Grant Taylor
-
Patent number: 7196221Abstract: Ionic compounds having a freezing point of no more than 50° C., formed by the reaction of at least one amine salt of the formula R1R2R3R4N+X? (I) with at least one hydrated salt, which is a chloride, nitrate, sulphate or acetate of Li, Mg, Ca, Cr, Mn, Fe, Co, Ni, Cu, Zn, Cd, Pb, Bi, La or Ce; wherein R1, R2 and R3 are each independently a C1 to C5 alkyl or a C6 to C10 cycloalkyl group, or wherein R2 and R3 taken together represent a C4 to C10 alkylene group, thereby forming with the N atom of formula (I) a 5 to 11 membered heterocyclic ring, and wherein R4 is hydrogen, or phenyl, or C1 to C12 alkyl or cycloalkyl group, optionally substituted with at least one group selected from OH, Cl, Br, F, I, phenyl, NH2, CN, NO2, COOR5, CHO, COR5 and OR5, wherein R5 is a C1 to C10 alkyl or cycloalkyl group, and X? is an anion capable of being complexed by the said hydrated salt.Type: GrantFiled: September 26, 2001Date of Patent: March 27, 2007Assignee: Scionix LimitedInventors: Andrew P. Abbott, David L. Davies, Glen Capper, Raymond K. Rasheed, Vasuki Tambyrajah
-
Patent number: 7196222Abstract: The present invention is directed to Form II of sertraline hydrochloride and novel methods for its preparation. According to the present invention, sertraline hydrochloride Form II may be produced directly form sertraline base or sertraline mandelate. It may also be produced from sertraline hydrochloride solvate and hydrate forms, and crystallized from new solvent systems. Pharmaceutical compositions containing sertraline hydrochloride Form II and methods of treatment using such pharmaceutical compositions are also disclosed.Type: GrantFiled: June 4, 2004Date of Patent: March 27, 2007Assignee: Teva Pharmaceutical Industries Ltd.Inventors: Eduard Schwartz, Tamar Nidam, Anita Liberman, Marioara Mendelovici, Judith Aronhime
-
Patent number: 7196223Abstract: A nitrile-containing mixture, which includes a nitrile dissolved in a higher alcohol solvent, and hydrogen are fed to a reactor containing a catalyst. An amine is produced by hydrogenating the nitrile that is dissolved in the higher alcohol solvent. In a preferred embodiment, the reactor also contains a caustic solution. The preferred nitrile-containing mixture includes octadecaneditrile (ODDN) and hexanol to produce a preferred octadecanediamine (ODDA) through hydrogenation.Type: GrantFiled: May 3, 2005Date of Patent: March 27, 2007Assignee: Solutia, Inc.Inventors: Tom L. Flowers, Anthony K. Uriarte, Shannon Davis, Gregory J. Ward
-
Patent number: 7196224Abstract: The invention provides 1,3,5-tris(arylamino)benzenes represented by the general formula (I) wherein A is naphthyl, anthryl, phenanthryl, biphenylyl or terphenylyl group, and R is alkyl having 1–6 carbon atoms or cycloalkyl group having five or six carbon atoms. The 1,3,5-tris(arylamino)benzenes have oxidation potentials in the range of about 0.5–0.6V, excellent reversibility in oxidation-reduction process and high glass transition temperatures and in addition, they are capable of forming stable and durable amorphous film useful as high performance organic semiconductors at normal temperatures or higher with no aid of binder resins, that is, by themselves.Type: GrantFiled: March 26, 2003Date of Patent: March 27, 2007Assignee: Bando Chemical Industries, Ltd.Inventors: Nobutaka Akashi, Hideki Norisada, Tomoko Hayashi, Yasuhiko Shirota
-
Patent number: 7196225Abstract: A bis(aminostyryl)anthracene compound represented by the general formula [I] or the like below. (where R2 and R3 each denotes an unsubstituted aryl group; R1 and R4 each denotes an aryl group having a specific substituent such as methoxy group; and R5 and R6 each denotes a cyano group or the like.) A process for producing a bis(aminostyryl)anthracene compound represented by the general formula [I] by condensation of, for example, 4-(N,N-diarylamino)benzaldehyde with diphosphonic ester or diphosphonium. The bis(aminostyryl)anthracene compound emits intense yellow or red light. The process permits efficient production of the bis(aminostyryl)anthracene compound. The bis(aminostyryl)anthracene compound emits intense yellow or red light. The process permits efficient production of the bis(aminostyryl)anthracene compound.Type: GrantFiled: June 15, 2005Date of Patent: March 27, 2007Assignee: Sony CorporationInventors: Mari Ichimura, Tadashi Ishibashi, Shinichiro Tamura
-
Patent number: 7196226Abstract: The present invention relates to fluorination reagents comprising 1-fluoro-1-aminoolefins and also processes for preparing fluorination reagents comprising 1-fluoro-1-aminoolefins.Type: GrantFiled: December 16, 2004Date of Patent: March 27, 2007Assignee: Lanxess Deutschland GmbHInventors: Wolfgang Ebenbeck, Albrecht Marhold
-
Patent number: 7196227Abstract: Disclosed is a process for the recovery of phosphorus and/or iodine containing catalyst components, present as an organophosphorus compound such as trihydrocarbylphosphine compounds and tetrahydrocarbylphosphonium compounds, from a solution of at least one such organophosphorus compound in an organic solvent by the steps comprising (1) converting the organophosphorus compound to an iodide complex of a organophosphonium compound which is insoluble in the organic solvent; and (2) separating the insoluble iodide complex of the organophosphonium compound from the solution. The process also results in the recovery of iodine values present in the solution.Type: GrantFiled: December 18, 2003Date of Patent: March 27, 2007Assignee: Eastman Chemical CompanyInventors: Jeffrey Scott Kanel, Stanley John Okrasinski
-
Patent number: 7196228Abstract: The invention relates to dimer and multimer form of BAPO compounds of the formula (I) dimer and multimer forms of MAPO compounds of the formula (II) wherein R1, R2, and R3 independently of one another are unsubstituted or substituted C1–C12alkyl, benzyl, C1–C12alkoxy, C3–C6cycloalkyl or C5–C14aryl; Q is a di- tri or tetravalent arylene residue; n is 1–4, m is 0–2, n+m is 2, 3 or 4, with the proviso, that R1 and R3 are different from each other.Type: GrantFiled: June 3, 2003Date of Patent: March 27, 2007Assignee: Ciba Specialty Chemicals CorporationInventors: Jean-Pierre Wolf, Gebhard Hug
-
Patent number: 7196229Abstract: The invention relates to benzoylcyclohexenone derivatives of general formula (I) wherein the variables R1 to R10 and n have the designation cited in claim 1.Type: GrantFiled: July 26, 2002Date of Patent: March 27, 2007Assignee: BASF AktiengesellschaftInventors: Wolfgang von Deyn, Ernst Baumann, Michael Hofmann, Markus Kordes, Ulf Misslitz, Liliana Parra Rapado, Cyrill Zagar, Matthias Witschel, Andreas Landes
-
Patent number: 7196230Abstract: A novel organophosphorus composition and synthesis thereof, the composition being characterized by one phosphite moiety, one phosoxophite moiety, and a plurality of sterically bulky substituents. The novel composition finds utility as a ligand in Group VIII transition metal phosoxophite complex catalysts and complex catalyst precursors that are used in carbonylation processes, preferably, hydroformylation processes. Additionally, there is disclosed a novel method of preparing a phosphoromonochloridite composition that finds utility as a precursor to the novel phosoxophite composition.Type: GrantFiled: March 4, 2003Date of Patent: March 27, 2007Assignee: Union Carbide Chemicals & Plastics Technology CorporationInventors: Wei-Jun Peng, David Robert Bryant
-
Patent number: 7196231Abstract: Acrolein is removed from a process stream such as a process stream generated in the manufacture of acrylonitrile. The process includes reacting the acrolein with a compound containing a reactable thiol or hydroxyl moiety in the presence of an acid catalyst. The present process provides for a refined process stream that contains no more than 5 ppm by weight unreacted acrolein.Type: GrantFiled: June 27, 2003Date of Patent: March 27, 2007Assignee: Solutia, Inc.Inventors: Gregory J. Ward, Bryan C. Blanchard, Scott G. Moffatt, Valerie S. Monical, Richard D. Murphy, Balshekar Ramchandran
-
Patent number: 7196232Abstract: Produce new 4,4?-dihydroxyphenyl bicyclohexenes that are useful as a material for liquid crystal polyester, polycarbonate, polyurethane or other synthetic resins or for photoresist used with display elements, semiconductors, etc., by thermally decomposing 4,4,4?4?-tetrahydroxyphenyl bicyclohexanes, preferably in the presence of alkali catalyst.Type: GrantFiled: October 16, 2003Date of Patent: March 27, 2007Assignee: Honshu Chemical Industry Co., Ltd.Inventors: Kouji Satomi, Hiroyasu Oono, Kenji Ekawa
-
Patent number: 7196233Abstract: Disclosed is a process for the preparation of alkylene glycols from the corresponding alkylene oxide, such as ethylene glycol from ethylene oxide, in the presence of water, a catalyst and, optionally, carbon dioxide. The catalyst contains an amphoteric compound, such as such as (ethylenedinitrilo) tetraacetic acid (EDTA). These befunctional compounds have both acid and base moieties. Preferably, a compound useful in the present invention forms a buffered solution in water, i.e., the acid and base moieties do not completely disassociate. The pH of the buffered solution should be 2-10, preferably 5-10, more preferably 4-9. A compound useful in the present invention is preferably organic with the base moiety and the acid moiety being separated by one to four carbon atoms.Type: GrantFiled: December 7, 2004Date of Patent: March 27, 2007Assignee: Saudi Basic Industries CorporationInventors: John S. Ledford, Jaap W. Van Hal, Xiankuan Zhang
-
Patent number: 7196234Abstract: The invention relates to a scalable biocatalytic process for the preparation of S-1,1,1-trifluoro-2-propanol with a enantiomeric excess of >99% by asymmetric microbial reduction of 1,1,1-trifluoroacetone with Baker's yeast.Type: GrantFiled: June 30, 2006Date of Patent: March 27, 2007Assignee: Hoffman-La Roche Inc.Inventors: Stephan Doswald, Steven Paul Hanlon, Ernst Kupfer
-
Patent number: 7196235Abstract: There is provided a process for producing a fluorinated vinyl ether from a fluorinated acid fluoride compound having an ester group as a precursor of a carboxylic acid group, or a SO2F group as a precursor of a sulfonic acid group, in high yield by simple operations. Said process is a production process comprising pyrolyzing a carboxylic acid potassium salt with a specific structure represented by the following formula in the absence of a solvent and/or while maintaining the salt in the solid state: wherein X is —CO2R or —SO2F, and R is an alkyl group.Type: GrantFiled: June 28, 2002Date of Patent: March 27, 2007Assignee: Asahi Kasei Kabushiki KaishaInventors: Nobuto Hoshi, Nobuyuki Uematsu, Masanori Ikeda
-
Patent number: 7196236Abstract: A catalytic one-step process for the production of CF3I by reacting, in the presence of a source of oxygen, a source of iodine a reactant of the formula: CF3R where R is —COOH, —COX, —CHO, —COOR2 and —SO2X, where R2 is an alkyl group and X is selected from chlorine, bromine and iodine. The catalyst may be a metal salt such as salts of Cu, Hg, Pt, Pd, Co, Mn, Rh, Ni, V, Tl, Ba, Cs, Ca, K and Ge and mixtures thereof, preferably on a support, such as MgO, BaO and CaO, BaCO3, CsNO3, Ba (NO3)2, activated carbon, basic alumina, and ZrO2.Type: GrantFiled: December 8, 2004Date of Patent: March 27, 2007Assignee: Honeywell International Inc.Inventors: Sudip Mukhopadhyay, HsuehSung Tung
-
Patent number: 7196237Abstract: A method of modifying a zeolite catalyst to increase selectivity of the catalyst is achieved by dissolving alumina in a phosphorus-containing acid solution, and treating the zeolite catalyst with the dissolved alumina solution. A method of preparing an aromatic product, such as a xylene product, is also achieved by contacting the modified zeolite catalyst with an aromatic hydrocarbon, such as toluene, and an alkylating agent, such as methanol, under reaction conditions suitable for aromatic alkylation. For xylene products the aromatic hydrocarbon may be toluene and the reaction conditions may be suitable for at least one of toluene methylation and transalkylation.Type: GrantFiled: May 20, 2005Date of Patent: March 27, 2007Assignee: Saudi Basic Industries CorporationInventors: Ashim Kumar Ghosh, Pamela Harvey
-
Patent number: 7196238Abstract: The invention relates to a process for dimerizing lower, olefinic hydrocarbons. In particular, the present invention concerns a process for dimerizing C3–, C4 and C5-olefins with a medium pore zeolite under process conditions allowing selective dimerization According to the invention, fresh olefinic hydrocarbon feedstock is fed to a reaction system including at least one reaction zone and at least one separation zone. The olefinic hydrocarbon feedstock is contacted with an acid catalyst at conditions in which at least a part of the olefins dimerizes. The effluent from the reaction zone is conducted to the separation zone where dimerized reaction product is separated from said effluent.Type: GrantFiled: March 10, 2003Date of Patent: March 27, 2007Assignee: Fortum OYJInventors: Matti Nurminen, Antti Pyhälahti, Pirjo Siira, Marja Tiitta
-
Patent number: 7196239Abstract: The present invention provides various processes for producing light olefins from methanol and ethanol, optionally in a mixed alcohol stream. In one embodiment, the invention includes directing a first syngas stream to a methanol synthesis zone to form methanol and directing a second syngas stream and methanol to a homologation zone to form ethanol. The methanol and ethanol are directed to an oxygenate to olefin reaction system for conversion thereof to ethylene and propylene.Type: GrantFiled: November 19, 2003Date of Patent: March 27, 2007Assignee: ExxonMobil Chemical Patents Inc.Inventors: Cornelis F. Van Egmond, Andrew Argo, Teng Xu, Marcel Johannes Janssen, Jaimes Sher
-
Patent number: 7196240Abstract: Methods and equipment are provided for making polybichlorophenyl non-toxic. Methods include a first oxidation step, in which polybichlorophenyl is burned, and a second oxidation step, in which exhaust gas from the first oxidation step is oxidized by contact with metallic phthalocyanines or metallic phthalocyanine derivatives and with an oxygen supply compound. Equipment includes a first furnace for burning a polybichlorophenyl-containing oil with an auxiliary fuel and a second oxidation reaction unit. The second oxidation reaction unit connects to the first furnace under seal, and includes metallic phthalocyanine or metallic phthalocyanine derivative solution supply source and an oxygen supply compound supply source.Type: GrantFiled: November 13, 2003Date of Patent: March 27, 2007Assignees: Ueda Textile Science FoundationInventors: Hirofusa Shirai, Mutsumi Kimura, Kenji Hanabusa, Kunihiro Hamada, Toshihiro Hirai
-
Patent number: 7196241Abstract: A sanitary napkin in which diffusing liquid hardly reaches a rear end edge is adapted to make a liquid absorbent layer less deformable in a rear region so that it can easily be kept in close contact with the wearer's buttocks. The sanitary napkin has an elongated main absorbent region surrounded by compressed grooves that are formed in a skin-side surface. Since a rear end of the main absorbent region is far away from a rear end edge of the napkin to provide a relatively large rear region, worries about rearward leakage may be relieved. Furthermore, since auxiliary longitudinal grooves are provided in the rear region, a liquid absorbent layer may hardly be twisted.Type: GrantFiled: May 7, 2004Date of Patent: March 27, 2007Assignee: Uni-Charm CorporationInventors: Masataka Kinoshita, Kazuya Nishitani, Toshiyuki Tanio, Akane Sakai
-
Patent number: 7196242Abstract: The present invention identifies a p53 homolog gene, cep-1, and mutations thereof in the nematode C. elegans which allows for the application of molecular genetic methods to identify new components of the p53 pathway as well as genes that act in parallel to the p53 pathway. cep-1 mutants show elevated physiological germ cell death during normal development. The present invention also provides a simple system with which to perform high-throughput screens for pharmacological agents that suppress the effects of eliminating the cep-1 gene or that enhance its effectiveness when in a mutant state. This strategy should identify agents that selectively kill p53-deficient cells that are resistant to traditional chemotherapeutic regimens and thus block the formation of human tumors that arise when p53 function is compromised.Type: GrantFiled: May 16, 2001Date of Patent: March 27, 2007Assignee: The Regents of the University of CaliforniaInventors: Joel H. Rothman, William Brent Derry
-
Patent number: 7196243Abstract: The present invention is directed toward a transgenic non-human animal and uses thereof, wherein each of the cells of the animal contain a transgene comprising a nucleic acid sequence encoding CD200.Type: GrantFiled: April 3, 2003Date of Patent: March 27, 2007Assignee: Trillium Therapeutics Inc.Inventor: Reginald M. Gorczynski
-
Patent number: 7196244Abstract: The present invention provides methods for generating and identifying mutations in Caenorhabditis elegans. Disclosed herein are methods for introducing DNA into the C. elegans germline, methods for expressing DNA in the C. elegans germline, and methods for generating C. elegans mutants by using controlled mobilization of endogenous and heterologous transposons. Also disclosed are a transgene construct for expression in C. elegans and methods for inserting single copy DNA sequences into the C. elegans germline, and engineering mutations into the C. elegans genome.Type: GrantFiled: June 1, 2000Date of Patent: March 27, 2007Assignee: University of UtahInventors: Jean-Louis Bessereau, Erik M. Jorgensen
-
Patent number: 7196245Abstract: The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant. These properties include increased biomass and increased tolerance to cold, water deprivation, and low nitrogen conditions.Type: GrantFiled: September 18, 2003Date of Patent: March 27, 2007Assignee: Mendel Biotechnology, Inc.Inventors: Cai-Zhong Jiang, Jacqueline E. Heard, Oliver Ratcliffe, Robert A. Creelman, Jose Luis Riechmann, Volker Haake
-
Patent number: 7196246Abstract: By linkage analysis, the Hd3a gene was successfully isolated. It was discovered that the flowering time of plant could be modified either by introducing the Hd3a gene or by controlling its expression.Type: GrantFiled: November 22, 2001Date of Patent: March 27, 2007Assignees: National Agriculture and Bio-oriented Research Organization, National Institute of Agrobiological Sciences, Society for Techno-Innovation of Agriculture, Forestry and FisheriesInventors: Masahiro Yano, Shoko Kojima
-
Patent number: 7196247Abstract: This invention relates to an isolated isoflavone synthase 1 (IFS1) promoter nucleic acid fragment. The invention also relates to the construction of chimeric genes comprising all or a portion of the IFS1 promoter directing the expression of transgenes, in sense or antisense orientation.Type: GrantFiled: March 22, 2002Date of Patent: March 27, 2007Assignee: E. I. du Pont de Nemours and CompanyInventors: Joan T. Odell, Xiaodan Yu, Xu Hu, Guihua Lu
-
Patent number: 7196248Abstract: A novel soybean cultivar, designated SG5322NRR, is disclosed. The invention relates to the seeds of soybean cultivar SG5322NRR, to the plants of soybean SG5322NRR and to methods for producing a soybean plant produced by crossing the cultivar SG5322NRR with itself or another soybean variety. The invention further relates to hybrid soybean seeds and plants produced by crossing the cultivar SG5322NRR with another soybean cultivar.Type: GrantFiled: January 23, 2004Date of Patent: March 27, 2007Assignee: Soygenetics, LLCInventor: Norman Van Meeteren